Abstract
We describe a series of dehydrophenylalanine derivatives where the Z isomers are potent VLA-4 antagonists but are subject to rapid biliary clearance and the E isomers have poor activity but have a slower rate of clearance. These configurationally constrained molecules have led to the design of a novel class of benzodiazepine VLA-4 antagonists.
MeSH terms
-
Animals
-
Benzodiazepines / chemistry
-
Benzodiazepines / pharmacology
-
Biliary Tract / metabolism
-
Drug Design
-
Inhibitory Concentration 50
-
Integrin alpha4beta1 / antagonists & inhibitors*
-
Isomerism
-
Phenylalanine / analogs & derivatives*
-
Phenylalanine / chemistry*
-
Phenylalanine / pharmacokinetics
-
Phenylalanine / pharmacology*
-
Rats
-
Structure-Activity Relationship
Substances
-
Integrin alpha4beta1
-
Benzodiazepines
-
Phenylalanine
-
phenyldehydroalanine